MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma

scientific article published on June 2004

MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1001990471
P356DOI10.1038/SJ.CGT.7700721
P698PubMed publication ID15118759
P5875ResearchGate publication ID8586073

P50authorDirk SchadendorfQ32649390
Walter MierQ88713133
P2093author name stringAnnette Paschen
Uwe Haberkorn
Helmut Eskerski
Stephanie Sieger
Heike Rothfels
Frank Schoensiegel
Juergen Kleinschmidt
P2860cites workThe extracellular human melanoma inhibitory activity (MIA) protein adopts an SH3 domain-like foldQ24536791
Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein MIAQ28272601
Recent advances in melanoma staging and therapyQ33718280
Thymidine kinase obliteration: creation of transgenic mice with controlled immune deficiencyQ33850269
Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cellsQ33914608
Enzymatic control of pigmentation in mammalsQ34631385
Adeno-associated virus vectors preferentially transduce cells in S phase.Q35754006
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cellsQ35864616
Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic proteinQ35943644
Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virusQ36159178
Regression of established macroscopic liver metastases after in situ transduction of a suicide geneQ36446693
Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors.Q36634983
Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcomaQ36853053
Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapyQ37593042
Targeted gene therapyQ40409150
Evaluation of combined gene regulatory elements for transcriptional targeting of suicide gene expression to malignant melanomaQ40600863
Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinaseQ41031158
Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesisQ41228936
Prostate tissue specificity of the prostate-specific antigen promoter isolated from a patient with prostate cancerQ41275954
Targeting of cytokine gene expression to malignant melanoma cells using tissue specific promoter sequences.Q41500661
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brainQ42280576
In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancersQ42474412
Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectorsQ42525047
Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expressionQ42805402
Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivoQ43692072
Tissue-specific gene expression in medullary thyroid carcinoma cells employing calcitonin regulatory elements and AAV vectorsQ43703255
Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinaseQ44166772
Liposomal encapsulation of ganciclovir enhances the efficacy of herpes simplex virus type 1 thymidine kinase suicide gene therapy against hepatic tumors in rats.Q45748615
Novel tools for production and purification of recombinant adenoassociated virus vectorsQ45752072
Recombinant adeno-associated virus for muscle directed gene therapyQ45764433
Increasing endothelial cell specific expression by the use of heterologous hypoxic and cytokine-inducible enhancersQ45868433
Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cellsQ45876121
Cutaneous melanomaQ67879576
The rate of malignant melanoma in the United States: are we making an impact?Q68835989
Targeted therapy for malignant melanomaQ72015768
S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanomaQ73181527
Cancer statistics, 2002: progress or cause for concern?Q77554842
P433issue6
P921main subjectsuicideQ10737
gene therapyQ213901
P304page(s)408-418
P577publication date2004-06-01
P1433published inCancer Gene TherapyQ15763088
P1476titleMIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma
P478volume11

Reverse relations

cites work (P2860)
Q46945028Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armoury
Q37353781Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth.
Q33327560Prodrug converting enzyme gene delivery by L. monocytogenes
Q35944371Promoters with cancer cell-specific activity for melanoma gene therapy.
Q36906143Safeguarding clinical translation of pluripotent stem cells with suicide genes
Q54112053Targeted gene therapy of the HSV-TK/hIL-12 fusion gene controlled by the hSLPI gene promoter of human non-small cell lung cancer in vitro.
Q35904008The use of gene therapy in cancer research and treatment
Q38011653Therapeutic live vaccines as a potential anticancer strategy.
Q36448393Treatment of human disease by adeno-associated viral gene transfer

Search more.